research communications\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890

Crystal structure of zwitterionic 3-(2-hy­dr­oxy-2-phospho­nato-2-phosphono­eth­yl)imidazo[1,2-a]pyridin-1-ium monohydrate (minodronic acid monohydrate): a redetermination

aR&D Division, PROCOS S.p.A., Via G. Matteotti 249, 28062 Cameri (Novara), Italy, and bUniversitá degli Studi di Parma, Dipartimento di Chimica, Parco Area delle Scienze 17/A, 43124 Parma, Italy
*Correspondence e-mail: corrado.rizzoli@unipr.it

Edited by H. Stoeckli-Evans, University of Neuchâtel, Switzerland (Received 4 December 2014; accepted 7 December 2014; online 1 January 2015)

In a previous study, the X-ray structure of the title compound, C9H12N2O7P2·H2O, was reported [Takeuchi et al., (1998[Takeuchi, M., Sakamoto, S., Kawamuki, K., Kurihara, H., Nakahara, H. & Isomura, Y. (1998). Chem. Pharm. Bull. 46, 1703-1709.]). Chem. Pharm. Bull. 46, 1703–1709], but neither atomic coordinates nor details of the geometry were published. The structure has been redetermined with high precision as its detailed knowledge is essential to elucidate the presumed polymorphism of minodronic acid monohydrate at room temperature. The mol­ecule crystallizes in a zwitterionic form with cationic imidazolium[1,2a]pyridine and anionic phospho­nate groups. The dihedral angle formed by the planes of the pyridine and imidazole rings is 3.55 (9)°. A short intra­molecular C—H⋯O contact is present. In the crystal, mol­ecules are linked by O—H⋯O, N—H⋯O and C—H⋯O hydrogen bonds and ππ inter­actions [centroid-to-centroid distance = 3.5822 (11) Å], forming a three-dimensional structure.

1. Chemical context

Minodronic acid, (1-hy­droxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-bis­(phospho­nic acid), has excellent bone resorption inhibitory activity, as well as anti-inflammatory, analgesic and anti­pyretic activities and is useful for the treatment of diseases in which an increased bone resorption participates (Tanishima & Morio, 2013[Tanishima, S. & Morio, Y. (2013). Clin. Interv. Aging, 8, 185-189.]; Yamane et al., 2003[Yamane, I., Hagino, H., Okano, T., Enokida, M., Yamasaki, D. & Teshima, R. (2003). Arthritis Rheum. 48, 1732-1741.]; Ito et al., 2010[Ito, M., Sone, T. & Fukunaga, M. (2010). J. Bone Miner. Metab. 28, 334-341.]; Sato et al., 2006[Sato, K., Yuasa, T., Nogawa, M., Kimura, S., Segawa, H., Yokota, A. & Maekawa, T. (2006). Br. J. Cancer, 95, 1354-1361.]). For practical uses and solid pharmaceutical preparations, the monohydrate form is preferred, giving more stable crystals with respect to the anhydrous and polyhydrate forms. By developing a pharmaceutical preparation (Takeuchi et al., 1993[Takeuchi, M., Hamada, M., Kaneko, Y. & Yamamoto, N. (1993). Eur. Patent EP 0647649B1.]), it was found that monohydrate crystals include two crystal forms, named D and E, having the same powder X-ray diffraction pattern but different dehydration temperatures. In fact, according to TG–DSC thermogravimetric analyses, crystal D has a dehydration peak temperature of 408 to 422 K, whereas for E it is 433 to 443 K.

[Scheme 1]

The monohydrate crystals of D and E are both produced by recrystallization of the free acid from aqueous hydro­chloric acid solutions by gradual cooling of a heat-dissolved solution under mild stirring conditions, followed by drying the crystals at 313–333 K under reduced pressure. The stirring mode and cooling conditions are the key factors in determining the final crystal form.

The relation between the two crystal forms deviates from the conventional concept of polymorphism by the similarity of the powder X-ray diffraction patterns. In principle, different mechanisms could be invoked to justify the different thermal behavior, amongst which a small difference in the crystal packing or in the atomic inter­actions could lead to it. The crystal structure of a monohydrate form of minodronic acid has been published earlier (Takeuchi et al., 1998[Takeuchi, M., Sakamoto, S., Kawamuki, K., Kurihara, H., Nakahara, H. & Isomura, Y. (1998). Chem. Pharm. Bull. 46, 1703-1709.]), but neither the atomic coordinates nor details of the mol­ecular and crystal geometry were reported. In the absence of detailed information, the present study of the crystal structures of both forms, D and E, was undertaken with the aim of finding a reasonable solution to the unusual `polymorphism' problem. Batches of the D and E crystals were prepared as described in the Experimental section and characterized by thermogravimetric analysis.

Powder X-ray diffraction was performed with a Thermo X'tra Diffractometer equipped with a Si(Li) solid state detector directly on the as-prepared samples without grinding (Fig. 1[link]). This confirmed that the diffraction patterns of the two forms involve peaks occurring at the same 2θ angles, the unique difference consisting of a different intensity distribution probably originating from preferential orientation. It is noteworthy that both diffraction patterns are fully compatible with the lattice parameters reported by Takeuchi et al. (1998[Takeuchi, M., Sakamoto, S., Kawamuki, K., Kurihara, H., Nakahara, H. & Isomura, Y. (1998). Chem. Pharm. Bull. 46, 1703-1709.]). Small single crystals suitable for XRD experiments were selected from both batches and their structures solved and refined. The analyses established that the crystal structures are perfectly comparable within experimental error, and compatible with that previously reported.

[Figure 1]
Figure 1
Comparison of the room-temperature powder X-ray diffraction patterns of forms D (red line) and E (blue line) of the title compound.

We report herein the redetermination of the crystal structure of form D of minodronic acid monohydrate, whereas that of form E has been deposited at the CCDC (Rizzoli & Calestani, 2014[Rizzoli, C. & Calestani, G. (2014). Private communication (deposition number 1037896). CCDC, Cambridge, England.]). On the basis of the present study, the peculiar thermal behaviour of the D and E forms of minodronic acid cannot be ascribed to structural differences, but it is probably due to morphological or microstructural features induced by the crystallization procedure and the influence of the dehydration process.

2. Structural commentary

The asymmetric unit of the title compound, Fig. 2[link], consists of minodronic acid and a water mol­ecule of crystallization. The acid mol­ecule crystallizes in a zwitterionic form with cationic imidazolium[1,2a]pyridine and anionic phospho­nate groups. The fused-ring system deviates from planarity, with the dihedral angle formed by the pyridine and imidazole rings being 3.55 (9)°. An analysis of the bond lengths within the fused-ring system, indicates that the C=N and C=C double-bond distribution shown in the Scheme is the most probable, but a resonant form involving the aromatic character of the pyridine ring and the localization of the positive change on the atom N2 also exists. The values of the P—O bond lengths indicate that the negative charge is delocalized on atoms O2 and O3, whose distances [P1—O2 = 1.5197 (10), P1—O3 = 1.5001 (10) Å] are inter­mediate between those observed for the protonated atoms O4, O5 and O7 [mean value 1.564 (7) Å] and for the localized P=O double bond [P2—O6 = 1.4817 (10) Å]. The observed distribution of the hydrogen atoms and of the charge on the phospho­nate groups differs from that deducible from the mol­ecular plot reported previously by Takeuchi et al. (1998[Takeuchi, M., Sakamoto, S., Kawamuki, K., Kurihara, H., Nakahara, H. & Isomura, Y. (1998). Chem. Pharm. Bull. 46, 1703-1709.]). An intra­molecular C—H⋯O hydrogen bond is present (Table 1[link]).

Table 1
Hydrogen-bond geometry (Å, °)

D—H⋯A D—H H⋯A DA D—H⋯A
O1—H1O⋯O8 0.78 (3) 1.87 (3) 2.6468 (18) 169 (2)
O4—H4O⋯O2i 0.90 (3) 1.73 (3) 2.6116 (16) 169 (3)
O5—H5O⋯O3ii 0.88 (3) 1.62 (3) 2.4973 (14) 175 (3)
O7—H7O⋯O2iii 0.83 (2) 1.80 (2) 2.6183 (14) 170 (2)
O8—H81⋯O6iv 0.82 (2) 1.99 (2) 2.8011 (15) 169 (3)
O8—H82⋯O6v 0.91 (2) 1.83 (2) 2.7334 (16) 175 (2)
N1—H1N⋯O5vi 0.85 (2) 2.18 (3) 2.9930 (15) 158 (2)
C2—H2B⋯O2 0.97 2.50 3.0224 (17) 114
C4—H4⋯O8 0.93 2.40 3.2079 (19) 145
C8—H8⋯O4vii 0.93 2.51 3.1704 (17) 128
Symmetry codes: (i) -x+1, -y, -z+1; (ii) -x+1, -y, -z; (iii) x-1, y, z; (iv) -x+1, -y+1, -z; (v) x+1, y, z; (vi) x, y+1, z; (vii) -x, -y, -z+1.
[Figure 2]
Figure 2
The mol­ecular structure of the title compound, showing the atom labelling. Displacement ellipsoids are drawn at the 50% probability level.

3. Supra­molecular features

The crystal structure of the title compound is characterized by a very effective hydrogen-bonding network which is responsible for the unusually high value of the calculated density of the crystal (1.818 g cm−3). As shown in Fig. 3[link], the crystal packing may be described as an alternate stacking along the b axis of phospho­nate and organic layers forming a three-dimensional network through O—H⋯O, N—H⋯O and C—H⋯O hydrogen bonds (Table 1[link] and Fig. 3[link]). Adjacent phospho­nate layers are bridged via hydrogen bonds involving the water mol­ecules, which are hosted inside channels parallel to the a axis and running between pairs of fused-ring systems connected by ππ inter­actions [Cg1⋯Cg1i = 3.5822 (11) Å; Cg1 is the centroid of the N2/C5–C9 ring; symmetry code: (i) −x, −y + 1, −z + 1]. The O—H⋯O hydrogen-bonding system within the phospho­nate layer (Fig. 4[link]) generates rings arranged in R22(8), R22(12), R42(16) and R44(16) graph-set motifs (Bernstein et al., 1995[Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N. L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.]).

[Figure 3]
Figure 3
The crystal packing of the title compound viewed along the a axis, showing the hydrogen-bonding network (violet dashed lines) and ππ inter­actions (blue dashed lines); see Table 1[link] for details.
[Figure 4]
Figure 4
A view along the b axis of the hydrogen-bonding network (dashed lines) in the phospho­nate layer (see Table 1[link] for detail). Nitro­gen, carbon (except C1) and C- and N-bound H atoms have been omitted for clarity.

4. Synthesis and crystallization

Crystal form D: crystals of minodronic acid (150 g) were added to 5.6 l of 1 N hydro­chloric acid (about 37.5 volumes) in a reactor equipped with mechanical stirring, and dissolved with heating. The dissolution temperature (368 K) was maintained for at least 30 min, followed by filtration of a small amount of undissolved particles. The clear filtrate was stirred at 110 r.p.m. and slowly cooled to 328 K in 4 h, and then to 295 K overnight. The crystalline precipitate was collected by filtration, washed with 300 ml of water and 300 ml of ethanol, and dried at 318 K to obtain 135 g of pure form D of minodronic acid monohydrate, as shown by the dehydration peak at 415 K (Takeuchi et al., 1993[Takeuchi, M., Hamada, M., Kaneko, Y. & Yamamoto, N. (1993). Eur. Patent EP 0647649B1.]). The colourless crystal sample used for X-ray analysis was selected from the batch.

Crystal form E: crystals of minodronic acid (15 g) were added to 0.6 l of 1 N hydro­chloric acid (about 40 volumes) in a reactor equipped with magnetic stirring and dissolved with heating. The dissolution temperature (368 K) was maintained for at least 30 min followed by filtration of a small amount of undissolved particles. The clear filtrate was stirred slowly so that the liquid surface could not create a vortex (<110 r.p.m.) and gradually cooled down to 295 K overnight. The crystal precipitate was collected by filtration, washed with 30 ml of water and 30 ml of ethanol, and dried at 318 K to obtain 14 g of pure E form of minodronic acid monohydrate, as shown by the dehydration peak at 438 K (Takeuchi et al., 1993[Takeuchi, M., Hamada, M., Kaneko, Y. & Yamamoto, N. (1993). Eur. Patent EP 0647649B1.]). The colourless crystal sample used for X-ray analysis was selected from the batch.

5. Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2[link]. All the H atoms were located in a difference Fourier map. The N- and O-bound hydrogen atoms were freely refined. The C-bound H atoms were refined using a riding model approximation, with C—H = 0.93–0.97 Å and with Uiso(H) = 1.2Ueq(C).

Table 2
Experimental details

Crystal data
Chemical formula C9H12N2O7P2·H2O
Mr 340.16
Crystal system, space group Triclinic, P[\overline{1}]
Temperature (K) 294
a, b, c (Å) 7.3668 (11), 8.9833 (12), 9.9733 (18)
α, β, γ (°) 75.0136 (17), 77.2716 (17), 88.5706 (18)
V3) 621.54 (17)
Z 2
Radiation type Mo Kα
μ (mm−1) 0.40
Crystal size (mm) 0.18 × 0.15 × 0.10
 
Data collection
Diffractometer Bruker SMART 1000 CCD
Absorption correction Multi-scan (SADABS; Bruker, 2008[Bruker (2008). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.])
Tmin, Tmax 0.640, 0.746
No. of measured, independent and observed [I > 2σ(I)] reflections 10459, 4054, 3413
Rint 0.020
(sin θ/λ)max−1) 0.752
 
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.035, 0.101, 1.07
No. of reflections 4054
No. of parameters 218
H-atom treatment H atoms treated by a mixture of independent and constrained refinement
Δρmax, Δρmin (e Å−3) 0.55, −0.28
Computer programs: APEX2 and SAINT (Bruker, 2008[Bruker (2008). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]), SIR97 (Altomare et al., 1999[Altomare, A., Burla, M. C., Camalli, M., Cascarano, G. L., Giacovazzo, C., Guagliardi, A., Moliterni, A. G. G., Polidori, G. & Spagna, R. (1999). J. Appl. Cryst. 32, 115-119.]), SHELXL2014 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]), ORTEP-3 for Windows (Farrugia, 2012[Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849-854.]), SCHAKAL99 (Keller, 1999[Keller, E. (1999). SCHAKAL99. Universität Freiburg, Germany.]) and publCIF (Westrip, 2010[Westrip, S. P. (2010). J. Appl. Cryst. 43, 920-925.]).

Supporting information


Computing details top

Data collection: APEX2 (Bruker, 2008); cell refinement: SAINT (Bruker, 2008); data reduction: SAINT (Bruker, 2008); program(s) used to solve structure: SIR97 (Altomare et al., 1999); program(s) used to refine structure: SHELXL2014 (Sheldrick, 2008); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012) and SCHAKAL99 (Keller, 1999); software used to prepare material for publication: publCIF (Westrip, 2010).

3-(2-Hydroxy-2-phosphonato-2-phosphonoethyl)imidazo[1,2-a]pyridin-1-ium monohydrate top
Crystal data top
C9H12N2O7P2·H2OZ = 2
Mr = 340.16F(000) = 352
Triclinic, P1Dx = 1.818 Mg m3
a = 7.3668 (11) ÅMo Kα radiation, λ = 0.71073 Å
b = 8.9833 (12) ÅCell parameters from 227 reflections
c = 9.9733 (18) Åθ = 8.2–21.3°
α = 75.0136 (17)°µ = 0.40 mm1
β = 77.2716 (17)°T = 294 K
γ = 88.5706 (18)°Block, colourless
V = 621.54 (17) Å30.18 × 0.15 × 0.10 mm
Data collection top
Bruker SMART 1000 CCD
diffractometer
3413 reflections with I > 2σ(I)
ω scanRint = 0.020
Absorption correction: multi-scan
(SADABS; Bruker, 2008)
θmax = 32.3°, θmin = 2.2°
Tmin = 0.640, Tmax = 0.746h = 1110
10459 measured reflectionsk = 1213
4054 independent reflectionsl = 1414
Refinement top
Refinement on F20 restraints
Least-squares matrix: fullHydrogen site location: mixed
R[F2 > 2σ(F2)] = 0.035H atoms treated by a mixture of independent and constrained refinement
wR(F2) = 0.101 w = 1/[σ2(Fo2) + (0.060P)2 + 0.1062P]
where P = (Fo2 + 2Fc2)/3
S = 1.07(Δ/σ)max = 0.001
4054 reflectionsΔρmax = 0.55 e Å3
218 parametersΔρmin = 0.28 e Å3
Special details top

Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) top
xyzUiso*/Ueq
P10.51328 (4)0.00236 (4)0.28423 (3)0.01430 (9)
P20.17313 (4)0.13064 (4)0.15681 (3)0.01514 (9)
O10.49943 (14)0.25308 (12)0.08484 (10)0.0206 (2)
H1O0.576 (3)0.303 (3)0.098 (2)0.039 (6)*
O20.67125 (13)0.05492 (12)0.33555 (10)0.0208 (2)
O30.56833 (15)0.09174 (12)0.17446 (11)0.0232 (2)
O40.37247 (14)0.10822 (11)0.41416 (11)0.0214 (2)
H4O0.349 (4)0.080 (3)0.496 (3)0.070 (8)*
O50.22204 (14)0.01195 (11)0.06740 (11)0.0213 (2)
H5O0.298 (4)0.044 (3)0.016 (3)0.072 (8)*
O60.10307 (14)0.27806 (12)0.08260 (12)0.0258 (2)
O70.03415 (14)0.04399 (13)0.29628 (11)0.0240 (2)
H7O0.079 (3)0.054 (3)0.300 (3)0.050 (7)*
O80.77583 (16)0.42957 (14)0.09502 (14)0.0301 (3)
H810.800 (3)0.515 (3)0.038 (3)0.049 (7)*
H820.884 (3)0.379 (3)0.086 (2)0.049 (6)*
N10.25482 (18)0.67430 (14)0.19284 (13)0.0225 (2)
H1N0.277 (3)0.769 (3)0.148 (2)0.047 (6)*
N20.09082 (15)0.46468 (12)0.31543 (12)0.0158 (2)
C10.38347 (17)0.16943 (14)0.21539 (13)0.0138 (2)
C20.34325 (19)0.26352 (15)0.32898 (14)0.0189 (2)
H2A0.25070.20610.40980.023*
H2B0.45650.27050.36190.023*
C30.27645 (18)0.42267 (15)0.28236 (14)0.0176 (2)
C40.3748 (2)0.55521 (16)0.20766 (15)0.0219 (3)
H40.50300.56370.17230.026*
C50.08150 (19)0.62025 (15)0.25700 (14)0.0182 (2)
C60.0888 (2)0.69424 (16)0.27288 (16)0.0236 (3)
H60.09650.79840.22950.028*
C70.2424 (2)0.60818 (17)0.35401 (17)0.0260 (3)
H70.35720.65410.36700.031*
C80.2293 (2)0.44988 (17)0.41874 (16)0.0240 (3)
H80.33500.39370.47660.029*
C90.06486 (19)0.37863 (15)0.39786 (15)0.0200 (3)
H90.05760.27370.43850.024*
Atomic displacement parameters (Å2) top
U11U22U33U12U13U23
P10.01367 (15)0.01350 (15)0.01500 (15)0.00313 (11)0.00231 (11)0.00340 (11)
P20.01371 (15)0.01476 (16)0.01648 (16)0.00114 (11)0.00367 (11)0.00301 (11)
O10.0207 (5)0.0207 (5)0.0165 (4)0.0069 (4)0.0002 (4)0.0004 (4)
O20.0134 (4)0.0274 (5)0.0221 (5)0.0026 (4)0.0045 (4)0.0072 (4)
O30.0304 (5)0.0192 (5)0.0202 (5)0.0075 (4)0.0029 (4)0.0084 (4)
O40.0239 (5)0.0183 (5)0.0185 (4)0.0037 (4)0.0016 (4)0.0008 (4)
O50.0248 (5)0.0190 (5)0.0213 (5)0.0009 (4)0.0038 (4)0.0084 (4)
O60.0243 (5)0.0199 (5)0.0327 (6)0.0059 (4)0.0123 (4)0.0016 (4)
O70.0138 (5)0.0324 (6)0.0216 (5)0.0010 (4)0.0005 (4)0.0024 (4)
O80.0204 (5)0.0258 (6)0.0404 (7)0.0019 (4)0.0044 (5)0.0036 (5)
N10.0259 (6)0.0131 (5)0.0244 (6)0.0003 (4)0.0008 (5)0.0028 (4)
N20.0186 (5)0.0112 (5)0.0179 (5)0.0024 (4)0.0037 (4)0.0044 (4)
C10.0132 (5)0.0131 (5)0.0142 (5)0.0004 (4)0.0017 (4)0.0028 (4)
C20.0235 (6)0.0156 (6)0.0192 (6)0.0063 (5)0.0070 (5)0.0060 (5)
C30.0188 (6)0.0149 (6)0.0198 (6)0.0035 (4)0.0034 (5)0.0070 (5)
C40.0206 (6)0.0193 (6)0.0247 (7)0.0010 (5)0.0007 (5)0.0077 (5)
C50.0236 (6)0.0121 (5)0.0183 (6)0.0021 (4)0.0033 (5)0.0040 (4)
C60.0277 (7)0.0164 (6)0.0273 (7)0.0077 (5)0.0080 (6)0.0059 (5)
C70.0221 (7)0.0264 (7)0.0324 (7)0.0079 (5)0.0074 (6)0.0121 (6)
C80.0197 (6)0.0240 (7)0.0271 (7)0.0017 (5)0.0015 (5)0.0075 (5)
C90.0222 (6)0.0153 (6)0.0211 (6)0.0018 (5)0.0029 (5)0.0038 (5)
Geometric parameters (Å, º) top
P1—O31.5001 (10)N2—C91.3743 (17)
P1—O21.5197 (10)N2—C51.3744 (16)
P1—O41.5745 (10)N2—C31.4004 (17)
P1—C11.8534 (13)C1—C21.5558 (17)
P2—O61.4817 (10)C2—C31.4914 (18)
P2—O51.5468 (10)C2—H2A0.9700
P2—O71.5625 (10)C2—H2B0.9700
P2—C11.8426 (13)C3—C41.3580 (19)
O1—C11.4233 (15)C4—H40.9300
O1—H1O0.78 (2)C5—C61.4022 (19)
O4—H4O0.90 (3)C6—C71.360 (2)
O5—H5O0.88 (3)C6—H60.9300
O7—H7O0.83 (2)C7—C81.412 (2)
O8—H810.83 (3)C7—H70.9300
O8—H820.91 (2)C8—C91.356 (2)
N1—C51.3363 (18)C8—H80.9300
N1—C41.3700 (18)C9—H90.9300
N1—H1N0.85 (2)
O3—P1—O2116.20 (6)P2—C1—P1115.68 (7)
O3—P1—O4107.20 (6)C3—C2—C1116.39 (11)
O2—P1—O4109.85 (6)C3—C2—H2A108.2
O3—P1—C1110.32 (6)C1—C2—H2A108.2
O2—P1—C1106.68 (6)C3—C2—H2B108.2
O4—P1—C1106.17 (6)C1—C2—H2B108.2
O6—P2—O5115.07 (6)H2A—C2—H2B107.3
O6—P2—O7113.46 (6)C4—C3—N2105.72 (11)
O5—P2—O7105.64 (6)C4—C3—C2129.60 (13)
O6—P2—C1109.47 (6)N2—C3—C2124.62 (12)
O5—P2—C1107.81 (6)C3—C4—N1109.01 (13)
O7—P2—C1104.75 (6)C3—C4—H4125.5
C1—O1—H1O111.6 (16)N1—C4—H4125.5
P1—O4—H4O116.9 (17)N1—C5—N2107.39 (11)
P2—O5—H5O116.7 (18)N1—C5—C6131.56 (13)
P2—O7—H7O118.0 (17)N2—C5—C6121.04 (12)
H81—O8—H82105 (2)C7—C6—C5117.60 (13)
C5—N1—C4109.26 (12)C7—C6—H6121.2
C5—N1—H1N121.0 (15)C5—C6—H6121.2
C4—N1—H1N129.6 (15)C6—C7—C8120.72 (13)
C9—N2—C5120.93 (11)C6—C7—H7119.6
C9—N2—C3130.37 (11)C8—C7—H7119.6
C5—N2—C3108.59 (11)C9—C8—C7120.97 (13)
O1—C1—C2112.48 (10)C9—C8—H8119.5
O1—C1—P2101.50 (8)C7—C8—H8119.5
C2—C1—P2112.69 (8)C8—C9—N2118.63 (12)
O1—C1—P1106.38 (8)C8—C9—H9120.7
C2—C1—P1107.91 (8)N2—C9—H9120.7
Hydrogen-bond geometry (Å, º) top
D—H···AD—HH···AD···AD—H···A
O1—H1O···O80.78 (3)1.87 (3)2.6468 (18)169 (2)
O4—H4O···O2i0.90 (3)1.73 (3)2.6116 (16)169 (3)
O5—H5O···O3ii0.88 (3)1.62 (3)2.4973 (14)175 (3)
O7—H7O···O2iii0.83 (2)1.80 (2)2.6183 (14)170 (2)
O8—H81···O6iv0.82 (2)1.99 (2)2.8011 (15)169 (3)
O8—H82···O6v0.91 (2)1.83 (2)2.7334 (16)175 (2)
N1—H1N···O5vi0.85 (2)2.18 (3)2.9930 (15)158 (2)
C2—H2B···O20.972.503.0224 (17)114
C4—H4···O80.932.403.2079 (19)145
C8—H8···O4vii0.932.513.1704 (17)128
Symmetry codes: (i) x+1, y, z+1; (ii) x+1, y, z; (iii) x1, y, z; (iv) x+1, y+1, z; (v) x+1, y, z; (vi) x, y+1, z; (vii) x, y, z+1.
 

Acknowledgements

The authors thank Mr A. Barozza, Dr J. Roletto and Dr P. Paissoni of PROCOS S.p·A. for useful discussions and valuable suggestions.

References

First citationAltomare, A., Burla, M. C., Camalli, M., Cascarano, G. L., Giacovazzo, C., Guagliardi, A., Moliterni, A. G. G., Polidori, G. & Spagna, R. (1999). J. Appl. Cryst. 32, 115–119.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationBernstein, J., Davis, R. E., Shimoni, L. & Chang, N. L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555–1573.  CrossRef CAS Web of Science Google Scholar
First citationBruker (2008). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.  Google Scholar
First citationFarrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationIto, M., Sone, T. & Fukunaga, M. (2010). J. Bone Miner. Metab. 28, 334–341.  Web of Science CrossRef PubMed CAS Google Scholar
First citationKeller, E. (1999). SCHAKAL99. Universität Freiburg, Germany.  Google Scholar
First citationRizzoli, C. & Calestani, G. (2014). Private communication (deposition number 1037896). CCDC, Cambridge, England.  Google Scholar
First citationSato, K., Yuasa, T., Nogawa, M., Kimura, S., Segawa, H., Yokota, A. & Maekawa, T. (2006). Br. J. Cancer, 95, 1354–1361.  Web of Science CrossRef PubMed CAS Google Scholar
First citationSheldrick, G. M. (2008). Acta Cryst. A64, 112–122.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationTakeuchi, M., Hamada, M., Kaneko, Y. & Yamamoto, N. (1993). Eur. Patent EP 0647649B1.  Google Scholar
First citationTakeuchi, M., Sakamoto, S., Kawamuki, K., Kurihara, H., Nakahara, H. & Isomura, Y. (1998). Chem. Pharm. Bull. 46, 1703–1709.  CrossRef CAS PubMed Google Scholar
First citationTanishima, S. & Morio, Y. (2013). Clin. Interv. Aging, 8, 185–189.  Web of Science CrossRef CAS PubMed Google Scholar
First citationWestrip, S. P. (2010). J. Appl. Cryst. 43, 920–925.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationYamane, I., Hagino, H., Okano, T., Enokida, M., Yamasaki, D. & Teshima, R. (2003). Arthritis Rheum. 48, 1732–1741.  Web of Science CrossRef PubMed CAS Google Scholar

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Follow Acta Cryst. E
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds